Volume 86 Issue 46 | p. 27 | Concentrates
Issue Date: November 17, 2008

Germany's Merck Starts Swiss Project

Department: Business
[+]Enlarge
Media and buffer preparation tanks at Merck's Corsier-sur-Vevey site.
Credit: Merck
8646bcon_merckcxdtif_opt
 
Media and buffer preparation tanks at Merck's Corsier-sur-Vevey site.
Credit: Merck

Merck KGaA's Merck Serono division is spending some $375 million to expand its production site in Corsier-sur-Vevey, Switzerland. The project will allow the company to boost output of Erbitux, the cancer-fighting monoclonal antibody that it markets with ImClone Systems. By 2010, Merck will add two production suites with a combined 120,000 L of bioreactor capacity.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment